Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
8.27
+0.36 (4.55%)
Mar 3, 2025, 4:00 PM EST - Market closed
Anavex Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 3, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Market Capitalization | 703 | 482 | 537 | 804 | 1,359 | 274 | |
| Market Cap Growth | 19.20% | -10.27% | -33.27% | -40.82% | 396.34% | 64.61% | |
| Enterprise Value | 612 | 343 | 382 | 651 | 1,202 | 246 | |
| Last Close Price | 7.91 | 5.68 | 6.55 | 10.32 | 17.95 | 4.55 | |
| PB Ratio | 6.06 | 4.00 | 3.78 | 5.65 | 9.01 | 10.06 | |
| P/TBV Ratio | 8.21 | 4.00 | 3.78 | 5.65 | 9.01 | 10.06 | |
| Quick Ratio | 9.39 | 8.80 | 12.27 | 14.92 | 14.93 | 4.67 | |
| Current Ratio | 9.45 | 8.86 | 12.32 | 14.95 | 14.97 | 4.73 | |
| Return on Equity (ROE) | -37.72% | -32.81% | -33.41% | -32.71% | -42.58% | -110.59% | |
| Return on Assets (ROA) | -24.34% | -21.81% | -21.59% | -18.95% | -23.87% | -55.77% | |
| Return on Capital (ROIC) | -26.87% | -24.12% | -23.32% | -20.31% | -26.29% | -70.26% | |
| Earnings Yield | -6.35% | -8.93% | -8.85% | -5.96% | -2.79% | -9.60% | |
| FCF Yield | -4.86% | -6.40% | -5.18% | -3.01% | -2.24% | -7.77% | |
| Buyback Yield / Dilution | -4.13% | -4.61% | -3.74% | -10.18% | -19.95% | -18.99% | |
| Total Shareholder Return | -4.13% | -4.61% | -3.74% | -10.18% | -19.95% | -18.99% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.